TFX Stock Forecast: Teleflex, Inc. Price Predictions for 2026-2027
The 12 Wall Street analysts covering Teleflex, Inc. hold a median 12-month price target of $169 — +4.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 93 of 100 as at 21 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Teleflex, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (100): The share count has been shrinking and the company is not leaning on new borrowing.
Quality (49): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
TFX stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on TFX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +4.6% from it.
Of the 20 most recent actions, 10 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Nov 2026 | Truist Securities | Maintains | Hold | $142 → $167 |
| 6 Nov 2026 | RBC Capital | Maintains | Outperform | $155 → $175 |
| 6 Nov 2026 | Wells Fargo | Maintains | Equal-Weight | $138 → $167 |
| 14 Oct 2026 | Truist Securities | Maintains | Hold | $150 → $142 |
| 28 Sept 2026 | B of A Securities | Upgrade | Buy | $145 → $158 |
| 25 Aug 2026 | Needham | Maintains | Buy | $159 → $170 |
| 11 Aug 2026 | UBS | Maintains | Neutral | $145 → $158 |
| 10 Aug 2026 | Truist Securities | Maintains | Hold | $143 → $150 |
| 7 Aug 2026 | Piper Sandler | Reiterates | Overweight | $160 → $169 |
| 31 July 2026 | Needham | Maintains | Buy | $147 → $159 |
| 28 July 2026 | UBS | Initiates | Neutral | $145 |
| 15 July 2026 | Mizuho | Maintains | Neutral | $140 → $145 |
| 9 July 2026 | BMO Capital | Initiates | Outperform | $159 |
| 8 June 2026 | Piper Sandler | Upgrade | Overweight | — |
| 11 May 2026 | Truist Securities | Reiterates | Hold | — |
| 8 May 2026 | RBC Capital | Upgrade | Outperform | — |
| 8 May 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 27 Mar 2026 | Raymond James | Upgrade | Outperform | — |
| 27 Feb 2026 | RBC Capital | Maintains | Sector Perform | — |
| 27 Feb 2026 | Wells Fargo | Maintains | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for TFX.
This page is one stock. Monday covers all of them.
TFX appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
TFX vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Teleflex, Inc. returned +55.9% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
TFX analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 81.6×
- Price / sales
- 2.9×
- Price / book
- 1.9×
- EV / EBITDA
- 16.4×
Cheaper than 10% of US stocks
Cheaper than 38% of US stocks
Cheaper than 45% of US stocks
Cheaper than 29% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 58.2%
- Operating margin
- 11.7%
- Net margin
- —
Higher than 71% of US stocks
Higher than 66% of US stocks
- Return on equity
- 2.4%
- Return on assets
- 2.3%
- Dividend yield
- 0.8%
Higher than 48% of US stocks
Higher than 60% of US stocks
Higher than 16% of US dividend payers
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Teleflex, Inc. has a market value of $6.5B and an enterprise value of $7.7B.
Revenue in the twelve months to 30 June 2026: $1.6B. The latest quarter shrank 27.0% year on year.
Net income over the same four quarters: −$1.0B, a −63.3% net margin.
Diluted earnings per share, trailing twelve months: −$23.29.
Free cash flow in the twelve months to 30 June 2026: $327.1M, after $76.1M of capital spending.
Teleflex, Inc. spent $250.0M on share buybacks and $59.9M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 81.6×; forward P/E: 15.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.83%, paying out 67% of earnings.
Teleflex, Inc. employs 15,500 people — $105K of revenue per employee.
Data provided by Twelve Data
TFX and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at TFX’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Teleflex, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about TFX
What is the TFX stock price forecast for 2026-2027?
The 12 Wall Street analysts covering Teleflex, Inc. have a median 12-month price target of $169, with estimates ranging from $158 to $178. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is TFX stock a buy right now?
Of the 12 analysts covering Teleflex, Inc., 6 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Teleflex, Inc. 93 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank TFX?
As at 21 Nov 2026, Teleflex, Inc. ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Issuance (100 of 100).
Will TFX stock go up?
No one can know that. What the data says: the median 12-month target from 12 analysts implies +4.6% from the last close, and Ticker Nerd's factor model ranks Teleflex, Inc. 93 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the TFX stock forecast for 2030?
No analyst covering Teleflex, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TFX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $158 to $178 over the next 12 months.
How has TFX stock performed over the past year?
Teleflex, Inc. returned +55.9% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Teleflex, Inc. do?
Teleflex Incorporated is a global medical technology company that designs, develops, manufactures, and supplies single-use devices used in critical care, surgery, and other hospital procedures. Teleflex Incorporated’s portfolio spans vascular access, anesthesia, emergency medicine, interventional cardiology and radiology, surgical applications, respiratory care, and urology, serving hospitals, healthcare providers, and medical device partners.
About Teleflex, Inc.
Teleflex Incorporated is a global medical technology company that designs, develops, manufactures, and supplies single-use devices used in critical care, surgery, and other hospital procedures. Teleflex Incorporated’s portfolio spans vascular access, anesthesia, emergency medicine, interventional cardiology and radiology, surgical applications, respiratory care, and urology, serving hospitals, healthcare providers, and medical device partners. The company also provides original equipment manufacturing services, supporting other medical device makers with components and specialized products. Its offerings are used in diagnostic and therapeutic procedures that require reliable, procedure-focused tools across a broad range of clinical settings. Headquartered in Wayne, Pennsylvania and founded in 1943, Teleflex Incorporated operates as a diversified healthcare equipment provider with a strong presence across the Americas, EMEA, and Asia.
CEO Mr. Jason Weidman · 15,500 employees · United States · https://www.teleflex.com